Cargando…

Analysis of Site-Specific Methylation of Tumor-Related Genes in Head and Neck Cancer: Potential Utility as Biomarkers for Prognosis

Clarifying the epigenetic regulation of tumor-related genes (TRGs) can provide insights into the mechanisms of tumorigenesis and the risk for disease recurrence in HPV-negative head and neck cancers, originating in the hypopharynx, larynx, and oral cavity. We analyzed the methylation status of the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misawa, Kiyoshi, Mochizuki, Daiki, Imai, Atsushi, Mima, Masato, Misawa, Yuki, Mineta, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789377/ https://www.ncbi.nlm.nih.gov/pubmed/29361757 http://dx.doi.org/10.3390/cancers10010027

Ejemplares similares

The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

Genes Located on 18q23 Are Epigenetic Markers and Have Prognostic Significance for Patients with Head and Neck Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018)

Aberrant Methylation Inactivates Somatostatin and Somatostatin Receptor Type 1 in Head and Neck Squamous Cell Carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2015)

Telomere shortening in head and neck cancer: association between DNA demethylation and survival
por: Yamada, Satoshi, et al.
Publicado: (2021)

Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017)

Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

5-Hydroxymethylcytosine and ten-eleven translocation dioxygenases in head and neck carcinoma
por: Misawa, Kiyoshi, et al.
Publicado: (2019)

Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
por: Mochizuki, Daiki, et al.
Publicado: (2018)

Late recurrence of breast carcinoma metastasis to the hypopharynx: a case report
por: Izumi, Chisako, et al.
Publicado: (2016)

G Protein-Coupled Receptor Genes, PTGDR1, PTGDR2, and PTGIR, Are Candidate Epigenetic Biomarkers and Predictors for Treated Patients with HPV-Associated Oropharyngeal Cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Neuropeptide receptor genes GHSR and NMUR1 are candidate epigenetic biomarkers and predictors for surgically treated patients with oropharyngeal cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

Long interspersed nuclear element 1 hypomethylation has novel prognostic value and potential utility in liquid biopsy for oral cavity cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2020)

DNA Methylation and HPV-Associated Head and Neck Cancer
por: Nakagawa, Takuya, et al.
Publicado: (2021)

Epigenetic inactivation of galanin receptors in salivary duct carcinoma of the parotid gland: Potential utility as biomarkers for prognosis
por: Kanazawa, Takeharu, et al.
Publicado: (2018)

Human papillomavirus-associated small cell carcinoma/neuroendocrine carcinoma of the oropharynx: a report of two cases
por: Misawa, Kiyoshi, et al.
Publicado: (2016)

Primary combined small and squamous cell carcinoma of the hypopharynx: A case report
por: MISAWA, KIYOSHI, et al.
Publicado: (2016)

G-Protein-Coupled Receptors: Next Generation Therapeutic Targets in Head and Neck Cancer?
por: Kanazawa, Takeharu, et al.
Publicado: (2015)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

Establishment of epigenetic markers to predict irradiation efficacy against oropharyngeal cancer
por: Kurokawa, Tomoya, et al.
Publicado: (2020)

CCTs as new biomarkers for the prognosis of head and neck squamous cancer
por: Dong, Yanbo, et al.
Publicado: (2020)

Abnormal Expressions of DNA Glycosylase Genes NEIL1, NEIL2, and NEIL3 Are Associated with Somatic Mutation Loads in Human Cancer
por: Shinmura, Kazuya, et al.
Publicado: (2016)

Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis
por: Yamada, Satoshi, et al.
Publicado: (2023)

Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells
por: Uehara, Takayuki, et al.
Publicado: (2014)

Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma
por: Ju, Guoyuan, et al.
Publicado: (2023)

DNA Methylation at the Novel CpG Sites in the Promoter of MED15/PCQAP Gene as a Biomarker for Head and Neck Cancers
por: Ovchinnikov, Dmitry A, et al.
Publicado: (2014)

An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma
por: Chen, Dayang, et al.
Publicado: (2021)

The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma
por: Zhao, Yaqiong, et al.
Publicado: (2022)

DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
por: Liouta, Galateia, et al.
Publicado: (2023)

Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma
por: Mochizuki, Daiki, et al.
Publicado: (2015)

Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy
por: Schernberg, Antoine, et al.
Publicado: (2018)

Utility of miRNA biomarkers for detection of early head and neck squamous cell carcinoma
por: Ershadifar, Soroush, et al.
Publicado: (2023)

Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
por: Minohara, Kiyoshi, et al.
Publicado: (2023)

Systematic analysis of differentially methylated expressed genes and site‐speciﬁc methylation as potential prognostic markers in head and neck cancer
por: Bai, Guohui, et al.
Publicado: (2019)

Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016)

Identification of HOXA1 as a Novel Biomarker in Prognosis of Head and Neck Squamous Cell Carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_95gm5t2acd51svl86pomrg95kh